Theramyt Novobiologics Company
Theramyt develops therapies for disease areas such as oncology, rheumatoid arthritis, diabetes, and metabolic disorders.
Investors
Funding Status:
Early Stage Venture
Industry:
PharmTech
Estimated Revenue:
$1M to $10M
Technology:
Biologics
Headquarters:
Bengaluru, Karnataka, India
Total Funding:
$1.5M
Last Funding Date:
2013-10-11
Last Funding Type:
Seed
Investor Type:
For Profit
Employee Number:
11-50
Investors Number:
5
Founded Date:
2013